Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Mar 15, 2022

SELL
$14.7 - $28.67 $129,271 - $252,123
-8,794 Closed
0 $0
Q3 2021

Oct 28, 2021

SELL
$24.31 - $33.6 $19,448 - $26,880
-800 Reduced 8.34%
8,794 $250,000
Q2 2021

Aug 10, 2021

BUY
$26.09 - $40.4 $250,307 - $387,597
9,594 New
9,594 $324,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Pinnacle Wealth Management Group, Inc. Portfolio

Follow Pinnacle Wealth Management Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Wealth Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Wealth Management Group, Inc. with notifications on news.